Saar Gill, MD: Combining CAR T-Cell Therapy With Ibrutinib in CLL Patients
1 Pogledi
• 07/14/23
0
0
Ugraditi
administrator
Pretplatnici
Adding ibrutinib to treatment with CAR T-cell therapy was feasible, led to deeper remissions, and reduced the severity of cytokine release syndrome in patients with chronic lymphocytic leukemia.
Prikaži više
Komentari na Facebooku
SORT BY-
Najbolji komentari
-
Najnoviji komentari